Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Operating Margin: 2018-2025

Historic Operating Margin for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to -558.64%.

  • Bicycle Therapeutics' Operating Margin rose 182723.00% to -558.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 5,056.14%, marking a year-over-year increase of 828076.00%. This contributed to the annual value of -17,489.33% for FY2024, which is 1390545.00% down from last year.
  • As of Q3 2025, Bicycle Therapeutics' Operating Margin stood at -558.64%, which was up 81.16% from -2,965.82% recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Operating Margin peaked at 331.81% during Q4 2023, and registered a low of -2,965.82% during Q2 2025.
  • For the 3-year period, Bicycle Therapeutics' Operating Margin averaged around -822.17%, with its median value being -558.64% (2025).
  • In the last 5 years, Bicycle Therapeutics' Operating Margin spiked by 186,954bps in 2022 and then slumped by 246,751bps in 2025.
  • Quarterly analysis of 5 years shows Bicycle Therapeutics' Operating Margin stood at -2,253.00% in 2021, then skyrocketed by 186,954bps to -383.46% in 2022, then surged by 71,528bps to 331.81% in 2023, then tumbled by 10,900bps to 222.82% in 2024, then soared by 182,723bps to -558.64% in 2025.
  • Its Operating Margin stands at -558.64% for Q3 2025, versus -2,965.82% for Q2 2025 and -703.66% for Q1 2025.